GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $631,943 | -80.5% | 12,728 | -76.6% | 0.01% | -82.1% |
Q2 2023 | $3,240,464 | +106.3% | 54,425 | +157.3% | 0.03% | +115.4% |
Q4 2022 | $1,570,885 | +62.6% | 21,151 | +30.6% | 0.01% | +62.5% |
Q3 2022 | $966,000 | -73.2% | 16,200 | -74.8% | 0.01% | -77.1% |
Q2 2022 | $3,611,000 | -69.4% | 64,327 | -59.7% | 0.04% | -67.0% |
Q1 2022 | $11,782,000 | -11.1% | 159,673 | -13.1% | 0.11% | -11.7% |
Q4 2021 | $13,260,000 | +5120.5% | 183,657 | +5513.0% | 0.12% | +3900.0% |
Q2 2021 | $254,000 | -65.1% | 3,272 | -77.8% | 0.00% | -78.6% |
Q3 2020 | $728,000 | -58.6% | 14,709 | -60.1% | 0.01% | -41.7% |
Q2 2020 | $1,760,000 | +414.6% | 36,902 | +535.7% | 0.02% | +200.0% |
Q4 2019 | $342,000 | -81.0% | 5,805 | -81.7% | 0.01% | -90.0% |
Q3 2018 | $1,799,000 | -55.2% | 31,700 | -60.2% | 0.08% | -63.3% |
Q2 2018 | $4,015,000 | +103.4% | 79,578 | +100.9% | 0.22% | +47.3% |
Q1 2018 | $1,974,000 | +656.3% | 39,618 | +350.5% | 0.15% | +469.2% |
Q1 2017 | $261,000 | – | 8,795 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |